ArticleFrontiers in pharmacology2023

Dynamics of abdominal symptoms during the start of a new therapy with elexacaftor/tezacaftor/ivacaftor using the novel CFAbd-day2day questionnaire.

Jochen G Mainz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.